Orally Administrated Olsalazine-Loaded Multilayer Pectin/Chitosan/Alginate Composite Microspheres for Ulcerative Colitis Treatment

Abstract

The pathogenesis of inflammatory bowel diseases (IBDs) including ulcerative colitis (UC) and Crohn’s disease is extremely cloudy. Maintaining the level of remission lesions in colitis is the default treatment attitude at present. Epithelial barrier restoration is considered as the same important strategy as colonic targeted drug delivery in UC treatment. In this paper, we developed a multilayer natural polysaccharide microsphere (pectin/chitosan/alginate) with pH and enzyme dual sensitivity to reduce the loss of medication in the upper digestive tract and preferentially adhere to exposed epithelial cells in colonic tissues by electrostatic forces for efficiently targeted UC treatment. Olsalazine as an inflammatory drug was efficiently loaded in the chitosan layer and realized a colonic pH-responsive drug release. Furthermore, the multilayer microspheres exhibited excellent capability in suppressing harmful flora and a bio-adhesion effect to extend the duration of local medicine. In the in vivo anti-colitis study, the downregulated levels of pro-inflammatory factors and the increase of tight junction protein indicated the excellent anti-inflammation effect of the olsalazine-loaded microspheres. In summary, these results showed that the multilayer natural polysaccharide microspheres could be a powerful candidate in the targeted drug delivery system for UC therapy.

Indigo Naturalis in Inflammatory Bowel Disease: mechanisms of action and insights from clinical trials

“…IN may offer potential benefits in treating IBD compared to well-established medications such as mesalazine, balsalazide, and olsalazine. These conventional medications alleviate inflammatory symptoms and slow the progression of IBD but do not effectively control beneficial bacteria or restore intestinal function [ 55 - 57 ]. However, IN’s clinical efficacy and safety profiles lack extensive validation compared to the well-established medications.…”

Hyaluronic Acid-Conjugated Thermoresponsive Polymer-Based Bioformulation Enhanced Wound Healing and Gut Barrier Repair of a TNBS-Induced Colitis Injury Ex Vivo Model in a Dynamic Perfusion Device

“…In addition to that, liquid enemas have drawbacks like prolonged operation times, leakage, and subpar patient compliance. In clinical research, hydrogels and natural polymer-based materials have attracted much interest for the treatment of digestive disorders. , For instance, an ascorbyl palmitate-based hydrogel is synthesized, which on enzymatic activation at the inflamed site resulted in the release of the encapsulated drug for treating colitis effectively . However, one of the major drawbacks associated with these hydrogels is the need for exceptionally high temperatures during their chemical synthesis, thus making the gel preparation step quite complicated.…”

pH-Responsive, Reactive Oxygen Species Scavenging and Highly Swellable Nanogel for Colon-Targeted Oral Drug Delivery

“…Time-dependent systems delay drug release until they reach the colon . Various formulations, including tablets, capsules, microparticles, and nanoparticles, are studied for targeted drug delivery to the colon. Microparticles and nanoparticles are usually favored due to their uniform size distribution, easy functionalization, tunable shape, and controlled drug release .…”